JPWO2022080249A1 - - Google Patents
Info
- Publication number
- JPWO2022080249A1 JPWO2022080249A1 JP2022556908A JP2022556908A JPWO2022080249A1 JP WO2022080249 A1 JPWO2022080249 A1 JP WO2022080249A1 JP 2022556908 A JP2022556908 A JP 2022556908A JP 2022556908 A JP2022556908 A JP 2022556908A JP WO2022080249 A1 JPWO2022080249 A1 JP WO2022080249A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020171646 | 2020-10-12 | ||
| PCT/JP2021/037311 WO2022080249A1 (ja) | 2020-10-12 | 2021-10-08 | 炎症性腸疾患の予防又は改善剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2022080249A1 true JPWO2022080249A1 (https=) | 2022-04-21 |
| JPWO2022080249A5 JPWO2022080249A5 (https=) | 2024-10-30 |
Family
ID=81208102
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022556908A Pending JPWO2022080249A1 (https=) | 2020-10-12 | 2021-10-08 |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JPWO2022080249A1 (https=) |
| WO (1) | WO2022080249A1 (https=) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003313173A (ja) * | 2002-02-22 | 2003-11-06 | Nippon Zoki Pharmaceut Co Ltd | ピペラジン誘導体 |
| WO2009046826A1 (en) * | 2007-09-11 | 2009-04-16 | Mondobiotech Laboratories Ag | Use of a cyclic penta-peptide as a therapeutic agent |
| JP2012214451A (ja) * | 2011-03-25 | 2012-11-08 | En Otsuka Pharmaceutical Co Ltd | 炎症性疾患用アミノ酸組成物 |
| JP2019214557A (ja) * | 2018-06-07 | 2019-12-19 | 国立大学法人金沢大学 | 腎障害の予防又は治療用の医薬組成物 |
| JP2021120359A (ja) * | 2020-01-30 | 2021-08-19 | 株式会社 資生堂 | 腸管バリア改善剤 |
| WO2021167032A1 (ja) * | 2020-02-18 | 2021-08-26 | 学校法人慶應義塾 | 腸炎および／または肝炎を治療および／または予防するための薬剤および食品 |
-
2021
- 2021-10-08 JP JP2022556908A patent/JPWO2022080249A1/ja active Pending
- 2021-10-08 WO PCT/JP2021/037311 patent/WO2022080249A1/ja not_active Ceased
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003313173A (ja) * | 2002-02-22 | 2003-11-06 | Nippon Zoki Pharmaceut Co Ltd | ピペラジン誘導体 |
| WO2009046826A1 (en) * | 2007-09-11 | 2009-04-16 | Mondobiotech Laboratories Ag | Use of a cyclic penta-peptide as a therapeutic agent |
| JP2012214451A (ja) * | 2011-03-25 | 2012-11-08 | En Otsuka Pharmaceutical Co Ltd | 炎症性疾患用アミノ酸組成物 |
| JP2019214557A (ja) * | 2018-06-07 | 2019-12-19 | 国立大学法人金沢大学 | 腎障害の予防又は治療用の医薬組成物 |
| JP2021120359A (ja) * | 2020-01-30 | 2021-08-19 | 株式会社 資生堂 | 腸管バリア改善剤 |
| WO2021167032A1 (ja) * | 2020-02-18 | 2021-08-26 | 学校法人慶應義塾 | 腸炎および／または肝炎を治療および／または予防するための薬剤および食品 |
Non-Patent Citations (2)
| Title |
|---|
| 岡田 かおり ほか: "黒酢及び米酢中のD-及びL-アミノ酸の定量的解析", 微量栄養素研究, vol. 29, JPN6021016344, 2012, pages 62 - 66, ISSN: 0005716172 * |
| 静間 徹 ほか: "黒酢によるデキストラン硫酸ナトリウム誘発性大腸炎の軽減効果", 外科と代謝・栄養, vol. 47, no. 1, JPN6021016343, 2013, pages 1 - 7, ISSN: 0005716171 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2022080249A1 (ja) | 2022-04-21 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230412 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240920 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20240920 |
|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20240920 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20240920 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20251027 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20251223 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20260108 |